ReligenDx

ReligenDx is a precision medicine company and CLIA-certified, CAP-accredited clinical laboratory based in San Jose, California. As the clinical service arm of Predicine, the company specializes in high-throughput genomic testing, including liquid biopsy and tissue-based Next-Generation Sequencing (NGS) for oncology. ReligenDx provides comprehensive molecular profiling services to support global clinical trials, companion diagnostic (CDx) development, and personalized patient management. The laboratory is equipped to handle complex genomic assays, offering end-to-end solutions from sample processing to data analysis and clinical reporting. Their mission is to empower healthcare providers and biopharmaceutical partners with actionable genomic insights to improve patient outcomes.